Introduction

Please help us improve our conferences for a better customer experience by completing this short event evaluation survey.  Our speakers, sponsors and event organizers will appreciate all your feedback.

Question Title

* 1. Name:

Question Title

* 2. Email Address:

Question Title

* 3. If you enjoyed the event, please provide a short testimonial of what you enjoyed at the event: (for publishing)

Question Title

* 4. What was the biggest area for improvement?

Question Title

* 5. What was your primary objective for attending the event?

Question Title

* 6. Did the event meet your objectives?

Question Title

* 7. How would you rate the speaker, content and subject matter of the following sessions?

  Excellent Very Good Fair Poor Very Poor
Day 1 - KEYNOTE: The success of phage therapy in the US: A patient’s view of receiving phage therapy - Professor Thomas Patterson, Dr Steffanie Strathdee
Day 1 - KEYNOTE: The evolutionary necessity for the development and uses of phage libraries for the individualized therapy of bacterial infections - Dr Carl Merril
Day 1 - KEYNOTE: Rational analysis of why phase II clinical trials have been failing - Dr Shawna McCallin
Day 1 - KEYNOTE: Regulatory and manufacturing compliance of phage therapy products - Dr Laurent Bretaudeau
Day 1 - Combining bacteriophages and antibiotics for wound infections - Dr Catherine Loc-Carrillo
Day 1 - The importance of phage evolution: phage therapy in three cases of MDR Pseudomonas aeruginosa infection - Dr Benjamin Chan
Day 1 - Sequence-specific antimicrobials: CRISP-Cas delivery via engineered phages - Xavier Duportet
Day 1 - Moving from vitro to vivo: Key characteristics and maximising efficacy by optimising the bacteriophage depth - Professor Martha Clokie
Day 1 - Precision microbiome engineering with CRISPR-weaponized phages - Dr Nick Conley
Day 1 - Importance of understanding phage-host interactions under potential treatment conditions in selecting therapeutic phages -  Betty Kutter
Day 1 - KEYNOTE: Utilizing Bacteriophages to Prevent Infections - Mark Engel
Day 1 - KEYNOTE: Personalized medicine model: The benefits and science considerations in expanded access cases - Dr Biswajit Biswas
Day 1 - KEYNOTE: Toward phage clinical trials for emerging markets - Dr Tobi Nagel
Day 1 - KEYNOTE: Commercial viability of precision phage therapy -  Greg Merril
Day 2 - KEYNOTE: Encouraging investment: NIAID perspective on and support for bacteriophage therapy -Dr Joe Campbell
Day 2 - KEYNOTE: Big Pharma View on the clinical utility and commercial opportunity for Phage therapy - Dr Carl Balibar
Day 2 - KEYNOTE: Obtaining phage therapy pharmacokinetic data via radiolabelled phage - Dr Derek Holman
Day 2 - KEYNOTE: Regulatory Considerations in the Development of Bacteriophage for Clinical Use - Cara Fiore
Day 2 - PANEL: Clinical trial vs compassionate use - Scott Stibitz, Brian Varnum, David Harper, Carrie-Lynn Langlais Furr, Shawna McCallin, Cara Fiore, Shawna McCallin
Day 2 - Effective usage of bacteriophage in industrial poultry farming: Importance of the delivery mechanism - Dr Jarek Dastych
Day 2 - Applying the veterinary model as a route to market - Dr David Harper
Day 2 - Bacteriophage lysins: novel non-traditional antimicrobial treatments for MDR pathogens - Dr Chandra Ghose
Day 2 - Engineering bacteriophage to combat infectious disease and remodel the microbiome - Dr Kevin Yehl
Day 2 - Can bacteriophages improve the microbiome and human health? - Dr Taylor Wallace
Day 2 - Applying traditional drug development approaches to phage therapy - Dr Magda Barbu
Day 2 - Achieving approval: proving your product is safe, pure and potent in the biologics license application - Dr Carrie-Lynn Langlais Furr
Day 2 - Commercial Considerations for Implementing Phage Therapy in Western Hospitals:  Pricing and Access Implications -Kate Kitsopoulos

Question Title

* 8. Who would you like to hear speak (not only from the previous speakers) at the next conference?

Question Title

* 9. Are there any other topics you'd like us to explore for future events?

Question Title

* 10. How did you hear about this event?

Question Title

* 11. Please rate the following features of the conference:

  Excellent Very Good Fair Poor Very Poor
Customer Service Before Event
Customer Service At Event
Program Relevance
Speaker Quality
Quality of Venue
Location of Venue
Catering

T